Y-mAbs’ External Control Problems May Sink Neuroblastoma Candidate I-Omburtamab

 
• By Derrick Gingery
  
Neuroblastoma cells
The FDA has not approved a therapy for neuroblastoma with CNS/LM relapse. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers